NDC00245-0040-11: POTASSIUM CHLORIDE EXTENDED-RELE.
POTASSIUM CHLORIDE EXTENDED-RELE. Key specifications include special_features: EQUIVALENT TO 8 MILLIEQUIVALENTS OF POTASSIUM, primary_container_type: BOTTLE, therapeutic_equivalent: SLOW-K BY SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 600.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-008-5994, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | EQUIVALENT TO 8 MILLIEQUIVALENTS OF POTASSIUM |
| primary_container_type | BOTTLE |
| therapeutic_equivalent | SLOW-K BY SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 600.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 600MG 100S BT |
| NSN | 6505-01-008-5994 |
| THERAPEUTIC EQUIVALENT | SLOW-K BY SUMMIT PHARMACEUTICALS,DIVISION OF CIBA-GEIGY CORPORATION |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | EQUIVALENT TO 8 MILLIEQUIVALENTS OF POTASSIUM |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | POTASSIUM CHLORIDE EXTENDED-RELEASE TABLETS USP 600MG 100S BT |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 600.000 MILLIGRAMS POTASSIUM CHLORIDE ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.